Table of Contents

Bone health is vital for everyone. Our bones do more than just support our bodies. They also protect vital organs, store minerals like calcium, and help us move. As we get older, keeping them strong becomes even more important, since weaker bones can lead to fractures and conditions like osteoporosis.

With the growing use of medications like Ozempic, more people are starting to wonder how it might affect bone health. This is especially relevant given how common both obesity and age-related bone loss are. Some concerns have been raised about whether long-term use, particularly with rapid weight loss, could have downsides for bone strength.

This article explains what the research says about Ozempic (semaglutide) and bone health, why weight loss can affect bones, and what you can do to protect them.

Key Takeaways

  • Rapid or large reductions in body weight reduce mechanical loading on the skeleton, leading to bone resorption and decreased bone density. Combine weight loss efforts with resistance and impact exercise to protect bones.
  • Clinical studies are mixed. Short-term trials show little difference in bone density between semaglutide users and controls, but markers of bone resorption may increase. Some observational studies suggest lower fracture risk compared with bariatric surgery, while others show neutral or higher risks.
  • Adequate calcium and vitamin D intake, moderate protein consumption, weight-bearing and resistance exercises, and balance training help maintain bone strength. Avoid smoking, excess alcohol, high sodium, and high caffeine.
  • Screening and risk assessment matter. DEXA scans are recommended for women 65 years and older and for younger women with risk factors. The FRAX tool estimates ten-year fracture risk and guides treatment decisions.

What is bone mineral density (BMD)?

Bone mineral density (BMD) refers to the amount of minerals, mainly calcium, present in a specific volume of bone. It’s a key measure used to assess bone strength and determine the risk of fractures.

Higher BMD generally means stronger bones, while lower BMD indicates weaker bones and a higher risk of conditions like osteopenia or osteoporosis. Doctors often measure BMD using a scan called a DEXA (dual-energy X-ray absorptiometry).

Does Ozempic damage bone density?

Doctor looking at results from a bone density scanner

Current evidence on the effects of Ozempic on bone density is mixed and still inconclusive. One of the most informative early trials was a 20-week pilot study in older adults comparing semaglutide plus lifestyle counseling with lifestyle counseling alone.

Participants using semaglutide lost about 5.3% of their body weight, whereas those on lifestyle counseling alone lost roughly 0.9%. Despite the greater weight loss, there were no statistically significant differences between the two groups in whole-body bone mineral density or bone turnover markers over the 20 weeks.

Another randomized trial, published in eClinicalMedicine in 2024, enrolled adults at increased risk of fractures (without diabetes) and compared once-weekly semaglutide with placebo over 52 weeks.

Researchers looked at P-P1NP (a marker of bone formation) and serum CTX (a marker of bone resorption). They found no significant difference in P-P1NP between the semaglutide and placebo groups at 52 weeks. However, serum CTX increased more in the semaglutide group, with an estimated difference of 166.1 ng/L at week 52.

These findings indicate that semaglutide may enhance bone resorption without substantially boosting bone formation in the first year, which could contribute to bone loss over time.

In a recent phase-2 trial, researchers compared semaglutide with other diabetes medications in older adults with type 2 diabetes. After adjusting for baseline characteristics, they observed an 11% increased risk of fragility fractures among GLP-1 RA users compared with those using other therapies.

Laboratory research also offers clues about how semaglutide might interact with bone cells. In one study using bone-related stem cells, researchers found that semaglutide helped the cells grow and turn into bone-forming cells. It also increased substances linked to bone formation and activated a pathway (called Wnt signaling) that is important for building bone. When this pathway was boosted, semaglutide’s effects were stronger. When it was blocked, the effects were reduced, although semaglutide still helped a bit.

Studies examining semaglutide and bone density

Research has provided mixed results for semaglutide:

  • Semaglutide versus bariatric surgery: A study followed 92,335 people taking semaglutide and compared them with 16,384 people who had sleeve gastrectomy. Semaglutide users had 26% lower fracture risk. The authors suggested that semaglutide’s weight loss is slower and less extreme than surgery, which may put less stress on bones.
  • Semaglutide and other GLP-1 receptor agonists: A meta-analysis of 47,823 patients found that GLP-1 receptor agonists reduced overall fracture risk by about 23% compared with other treatments. The benefit appeared after 78 weeks of therapy, suggesting that longer exposure may be protective or that fractures take time to occur. Liraglutide showed the most pronounced benefit, whereas evidence for semaglutide was less clear. This shows that not all GLP-1 drugs have identical effects on bone.
  • Case-control and cohort studies: A Danish study compared 337,648 fracture cases with 675,296 controls. After adjusting for risk factors, people using GLP-1 RAs had a lower risk of fractures, with about a 6% reduction in overall fractures and a 12% reduction in major osteoporotic fractures. In contrast, a US study of adults with type 2 diabetes found that GLP-1 RA users had a higher risk of certain bone conditions. At five years, patients using GLP-1 drugs had a 29% higher risk of osteoporosis, 12% higher risk of gout, and 2.5 times higher risk of osteomalacia compared with controls.
  • SELECT trial safety analysis: A safety analysis of the SELECT trial published in 2025 reported that overall fracture rates were similar in the semaglutide and placebo groups (1.5% vs 1.7%). However, among women and people aged 75 years and older, there were numerically higher rates of hip and pelvic fractures in those taking semaglutide.

In sum, semaglutide’s effects on bone are unclear. Some studies suggest it may lower fracture risk, while others show no effect or a slight increase. These differences likely reflect variations in study design and patient groups. One consistent finding, however, is that greater weight loss is linked to bigger declines in bone density, suggesting that rapid weight loss may weaken bone.

Buy Generic Semaglutide from Canada
Generic Semaglutide COMING SOON!

Fill out the form below and get notified when generic semaglutide pens are in stock, and receive a one-time 10% OFF coupon code.

This field is for validation purposes and should be left unchanged.
Subscribe to SMS Alerts

How weight loss affects bone density

Bone is a living tissue that constantly remodels itself, and weight loss can be a double-edged sword for bone health.

Losing excess body fat reduces the mechanical load that bones carry, especially on weight-bearing joints like knees, hips, and spine. This often leads to reduced pain and improved mobility.

However, our bones adapt to the loads placed upon them. Carrying extra body weight stimulates bone formation to support a heavier load. On the other hand, rapid or large reductions in weight reduce the stimulus for bone formation. This can lead to bone turnover, meaning that cells that remove bone (osteoclasts) become more active relative to cells that build bone (osteoblasts).

A review found that diet-induced weight loss led to significant losses of femoral neck bone mineral density (BMD) and total hip BMD. This shows that weight loss itself, regardless of how it is achieved, can put bones at risk unless protective measures, such as exercise and proper nutrition, are taken.

Other factors contributing to low bone mass

Several other factors contribute to lower bone mass, including:

  • Changes in hormones: Weight loss can decrease levels of hormones like estrogen, testosterone, and insulin-like growth factor 1 (IGF-1) that help maintain bone. Lower estrogen is particularly harmful in women because it accelerates bone resorption.
  • Bone marrow adiposity: As body fat decreases, fat cells in bone marrow may expand to store excess lipids. This process can also inhibit osteoblasts (bone-forming cells) and promote osteoclast activity, tipping the balance toward bone loss.
  • Nutritional deficiencies: People trying to lose weight often cut calories, which may reduce intake of calcium, vitamin D, and protein. These nutrients are vital for bone formation and maintenance. Without them, bones cannot rebuild properly.
  • Energy metabolism: During weight loss, the body uses stored energy, altering metabolic pathways. This can affect hormones like leptin and adiponectin that influence bone turnover. The overall result may be increased bone resorption.

While Ozempic may have direct effects on bone, the accompanying weight reduction and other factors are likely a major driver of any bone changes. So, take steps to protect your bone health by focusing on diet, exercise, and monitoring.

Assessing bone health while taking Ozempic

Given the uncertainty surrounding Ozempic’s effects on bone density, keeping an eye on your bone health becomes an important part of long-term use.

Recognizing signs of poor bone health

Bone loss often goes unnoticed until a fracture occurs, but certain signs may hint at declining bone density. Watch for:

    • Unexplained bone pain or tenderness. Aching in the hips, ribs, or spine that has no clear cause could signal weakened bones.
    • Loss of height or a stooped posture. Gradual reduction in height or forward curvature of the spine can result from vertebral compression fractures.
    • Broken bones from minimal trauma. Fractures after minor falls or routine activities are red flags for osteoporosis.
    • Receding gums and poor oral health. Bone loss in the jaw can accompany systemic bone thinning.

If any of these symptoms appear, consult a healthcare provider for evaluation. It is important not to blame Ozempic alone without proper assessment because other factors, such as age, menopause, smoking, or medications, can also weaken bones.

Bone density testing (DEXA scans)

The primary tool for measuring bone density is a dual-energy X-ray absorptiometry (DEXA) scan. DEXA uses low-dose X-rays to measure bone thickness at the hip and spine.

According to the US Centers for Disease Control and Prevention, DEXA scans are recommended for women aged 65 or older and for women aged 50 to 64 who have risk factors, such as having a parent who broke a hip. Other risk factors include:

    • low body weight
    • certain intestinal disorders
    • smoking
    • long-term use of glucocorticoids

The scan is non-invasive, takes about 15-20 minutes, and produces a T-score comparing your bone density with that of a healthy young adult, and a Z-score comparing it with peers of the same age and sex. These scores help doctors diagnose osteoporosis or osteopenia and monitor changes over time.

Using the FRAX tool to estimate fracture risk

Clinicians often combine DEXA results with other factors to estimate fracture risk using the Fracture Risk Assessment Tool (FRAX). It integrates bone density with age, sex, weight, history of fractures, smoking, and steroid use to calculate a ten-year probability of hip fracture and major osteoporotic fracture.

The Bone Health & Osteoporosis Foundation explains that FRAX is intended for postmenopausal women or men aged 50 and older who have low bone density and have not yet taken osteoporosis medication.

If your DEXA report does not include a FRAX estimate, your healthcare provider can compute it using a web-based calculator. This helps guide decisions about preventive treatments such as bisphosphonates or hormone therapy.

Practical strategies to protect your bones while on Ozempic

Man Stretching Leg on Track With X-ray Overlay

There are evidence-based steps you can take to maintain strong bones during weight loss.

Nutrition

Focusing on the right nutrients can help support bone health. Here are the most important vitamins and minerals to include.

Calcium intake

Calcium is the main mineral in bone. The Bone Health & Osteoporosis Foundation recommends:

    • women aged 50 or younger and men up to age 70 get 1,000 mg of calcium per day
    • women over 50 and men over 70 should aim for 1,200 mg per day

Food sources such as milk, yogurt, cheese, fortified plant milks, sardines, and leafy greens are preferable to supplements. If you cannot get enough calcium from your diet alone, small supplemental doses may be necessary.

It is best to divide supplements into amounts of 500-600 mg or less for optimal absorption. Avoid taking more calcium than you need because excess calcium can cause kidney stones or constipation.

Vitamin D

Vitamin D helps the body absorb calcium and supports muscles needed for balance.

    • adults under 50 should consume 400-800 international units (IU) of vitamin D per day
    • adults 50 or older should aim for 800-1,000 IU daily

Sunlight triggers the skin to produce vitamin D, but factors like latitude, time indoors, and sunscreen use can limit production. Dietary sources include fatty fish (such as salmon and mackerel), fortified milk, and cereals. Many people need supplements to reach the recommended intake, particularly in winter or if they have darker skin or malabsorption conditions.

Protein

Adequate protein is essential for bone and muscle. Contrary to the myth that high-protein diets harm bones, research shows that protein supports bone health by increasing IGF-1, promoting calcium absorption, and building muscle mass.

A moderate increase in protein intake above the Recommended Dietary Allowance (0.8 g per kilogram of body weight per day) may benefit older adults. However, extremely high protein intake (more than about 1.5 g/kg) could increase acid load and calcium excretion, so balance is important.

Many older adults do not get enough protein, and diets that include multiple servings of meat or other protein at every meal may cause calcium loss if not balanced with calcium-rich foods. Choose a mix of plant and animal proteins, and ensure you meet your calcium and vitamin D needs.

Other nutrients

Magnesium, vitamin K, and omega-3 fatty acids support bone health as well. Green leafy vegetables, nuts, seeds, and fish provide these nutrients.

Limiting sodium and caffeine intake is also important because high salt and caffeine can increase calcium loss. Excessive alcohol consumption damages bone, so drink in moderation.

Exercise

Physical activity is one of the best ways to preserve bone during weight loss. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) explains that exercise prevents bone loss, makes bones denser, and improves balance and coordination. It also strengthens muscles, which reduces the risk of falls.

A combination of different types of exercise works best:

  • Weight-bearing exercises: Activities that work against gravity while staying upright stress the bones and stimulate formation. NIAMS lists brisk walking (3-4 mph), jogging, running, tennis, and dancing among effective options. The Bone Health & Osteoporosis Foundation divides weight-bearing exercises into high-impact (jumping rope, jogging, stair climbing, dancing, and tennis) and low-impact (brisk walking, hiking on level surfaces, elliptical machines, and stair-step machines).
  • Resistance training: Lifting weights, using resistance bands, or performing body-weight exercises like squats and push-ups strengthens muscles and bones. NIAMS notes that resistance training adds stress to bones, encouraging them to become stronger.
  • Balance and coordination exercises: Activities that improve balance help prevent falls. Examples include tai chi, yoga, walking on unstable surfaces, lunges, and step-ups. Simple exercises like shifting weight from one foot to the other or practicing single-leg stands can also improve balance.

For adults who are medically able, aim for at least 150 minutes of moderate-intensity exercise per week (such as brisk walking) or 75 minutes of vigorous exercise (such as running), combined with muscle-strengthening activities on two or more days each week.

If you have osteoporosis or other health conditions, consult a healthcare provider before starting high-impact activities. A physical therapist or trainer experienced in bone health can suggest safe routines.

Lifestyle habits and fall prevention

Beyond diet and exercise, several lifestyle choices influence bone health:

    • Avoid smoking. Tobacco impairs bone formation and reduces estrogen levels, accelerating bone loss.
    • Moderate alcohol. Heavy drinking interferes with calcium absorption and increases fracture risk.
    • Maintain adequate body weight. While losing excess weight improves many health parameters, extremely low body weight increases fracture risk because bones are less stimulated. Set realistic weight-loss goals in consultation with your doctor, and avoid crash diets.
    • Limit high-sodium and high-caffeine foods. Too much salt or caffeine causes calcium to be excreted in urine.
    • Prevent falls at home. Clear clutter, secure rugs, use handrails on stairs, and install night-lights. Wear supportive shoes and consider assistive devices if your balance is impaired.

Bottom line

The studies about Ozempic and bone health are mixed and evolving. Clinical studies show that semaglutide does not drastically reduce bone density over short periods, but some data hint at increased bone resorption or increased fracture risk in certain populations. Laboratory experiments suggest that semaglutide may stimulate bone formation by activating Wnt signaling.

Consider getting a baseline DEXA scan before starting Ozempic or other GLP-1 drugs, especially if you have risk factors like menopause, a history of fractures, smoking, or long-term steroid use. Repeat bone density testing every one to two years, or as recommended by your doctor. Use FRAX calculations to assess fracture risk and decide whether preventive medications are needed.

If bone loss is detected, your healthcare provider may suggest osteoporosis medications, hormone therapy, or adjustments to your weight-loss plan. The risks and benefits should be weighed individually.

Frequently Asked Questions

Current evidence is mixed. Some studies suggest neutral or even protective effects on fracture risk, while others note small decreases in bone density, especially with significant weight loss. Overall, its direct impact on bones is still uncertain.

Joint pain is not a common direct side effect, but some people report discomfort, which may be related to weight changes or underlying conditions. Rapid weight loss can sometimes affect joints indirectly.

No single vitamin can rebuild bone on its own, but vitamin D is essential because it helps the body absorb calcium, which is critical for bone strength.

The most effective approach combines weight-bearing exercise, adequate calcium and vitamin D intake, and addressing any underlying medical issues. In some cases, medications may be needed for faster improvement.

Dairy products like milk, yogurt, and cheese are among the richest and most easily absorbed sources of calcium.

There is no strong evidence that Ozempic directly alters vitamin D levels. However, dietary changes or weight loss could indirectly influence nutrient status.

Yes, calcium supplements can generally be taken alongside Ozempic. There are no known harmful interactions, but it’s best to follow recommended doses.

There is no clear evidence that Ozempic directly depletes calcium. Any changes in bone health are more likely linked to weight loss rather than calcium loss itself.

Related Articles

Sources

Dinkla, L., Beavers, K. M., Robbins, R., Akpalu, D., Wherry, S. J., Miller, G., Beavers, D. P., Espinoza, S., Trejo, J., Stepanenko, A., & Cortes, T. M. (2025). Bone mineral density and turnover response to GLP-1 receptor agonists in older adults with overweight/obesity and prediabetes/type 2 diabetes: a 20-week pilot trial post hoc analysis. Frontiers in Aging, 6, 1691007. https://doi.org/10.3389/fragi.2025.1691007

Hansen, M. S., Wölfel, E. M., Jeromdesella, S., Møller, J. K., Ejersted, C., Jørgensen, N. R., Eastell, R., Hansen, S. G., & Frost, M. (2024). Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial. EClinicalMedicine, 72, 102624. https://doi.org/10.1016/j.eclinm.2024.102624

Meron, M. K., Hornik-Lurie, T., Twig, G., & Rotman-Pikielny, P. (2026). GLP-1 receptor agonists and the risk of fragility fractures in older adults with type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag056

Mesinovic, J., Jansons, P., Zengin, A., De Courten, B., Rodriguez, A. J., Daly, R. M., Ebeling, P. R., & Scott, D. (2021). Exercise attenuates bone mineral density loss during diet-induced weight loss in adults with overweight and obesity: A systematic review and meta-analysis. Journal of Sport and Health Science/Journal of Sport and Health Science, 10(5), 550–559. https://doi.org/10.1016/j.jshs.2021.05.001

Tian Y, Liu H, Bao X, Li Y. Semaglutide promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells through activation of the Wnt/LRP5/?-catenin signaling pathway. Front Pharmacol. 2025 Mar 10;16:1539411. doi: 10.3389/fphar.2025.1539411. PMID: 40129942; PMCID: PMC11931165.

Noreña JA, Pike CW, Hui G, Motlaghzadeh Y, Sellmeyer DE, Wu JY, Kim SH. Comparison of Fracture Risk Following Semaglutide Treatment vs Sleeve Gastrectomy. AACE Endocrinol Diabetes. 2025 Oct 20;12(4):308-313. doi: 10.1016/j.aed.2025.10.001. PMID: 41467149; PMCID: PMC12744784.

Zhang, Y., Chen, G., Wang, W., Yang, D., Zhu, D., & Jing, Y. (2024). Association of Glucagon-like peptide-1 receptor agonists use with fracture risk in type 2 diabetes: A meta-analysis of randomized controlled trials. Bone, 192, 117338. https://doi.org/10.1016/j.bone.2024.117338

Kvist, A. V., Andersen, S. S., Vestergaard, P., & Viggers, R. (2026). The association between GLP-1 receptor agonists and fractures: a nationwide Danish nested case-control study. Osteoporosis International. https://doi.org/10.1007/s00198-026-07950-6

Drugs.com. (2026, March 6). AAOS: GLP-1 Receptor Agonist use Increases Five-Year Risk for Osteoporosis MedNews. Drugs.com. https://www.drugs.com/news/aaos-glp-1-receptor-agonist-increases-five-year-risk-osteoporosis-129071.html

Facts about bone density (DEXA scan). (2025, January 30). Radiation and Your Health. https://www.cdc.gov/radiation-health/data-research/facts-stats/dexa-scan.html

Bone Health and Osteoporosis Foundation. (2025, July 23). Osteoporosis Risk Assessment (FRAX®): 10-Year fracture risk. Bone Health & Osteoporosis Foundation. https://www.bonehealthandosteoporosis.org/patients/diagnosis-information/risk-assessment-frax/

Surdykowski AK, Kenny AM, Insogna KL, Kerstetter JE. Optimizing bone health in older adults: the importance of dietary protein. Aging health. 2010 Jun 1;6(3):345-357. doi: 10.2217/ahe.10.16. PMID: 20657805; PMCID: PMC2907525.

Branch, N. S. C. a. O. (2025, June 5). Exercise for your bone health. National Institute of Arthritis and Musculoskeletal and Skin Diseases. https://www.niams.nih.gov/health-topics/exercise-your-bone-health

Kushner RF, Ryan DH, Deanfield J, Kokkinos A, Cercato C, Wilding J, Burguera B, Wu CC, Craciun AE, Pall D, Hramiak I, Hjelmesæth J, Harder-Lauridsen NM, Weimers P, Jeppesen OK, Kallenbach K, Lincoff AM, Lingvay I. Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial. Obesity (Silver Spring). 2025 Mar;33(3):452-462. doi: 10.1002/oby.24222. Epub 2025 Feb 13. PMID: 39948761; PMCID: PMC11897845.